Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals is a biopharmaceutical company focused on novel therapeutic products for the treatment of central nervous system disorders. The company last month received a grant from the Michael J. Fox Foundation to test AVP-923 in the treatment of levodopa-induced-dyskinesia (LID) in Parkinson’s disease.
Going forward ... (see research report)
Subscribe to News Feeds